Pharmacodynamics and pharmacokinetics of two dose regimens of befloxatone, a new reversible and selective monoamine oxidase inhibitor, at steady state in healthy volunteers.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples